CellRapeutics™ Leukopak from Osteoarthritis Donor (XS-0426-XU256)

Name: CellRapeutics™ Leukopak from Osteoarthritis Donor
SKU: XS-0426-XU256
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Procured from donors with clinical and radiographic evidence of Osteoarthritis, this Leukopak reflects the low-grade systemic inflammatory component of degenerative joint disease. The cell population is characterized by distinct monocyte activation patterns and alterations in the innate immune compartment linked to cartilage catabolism. This product supports research into the "inflammaging" aspect of OA and the systemic drivers of joint-related chronic pain and disability.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Osteoarthritis Donor

Cat. No.
XS-0426-XU256

Donor Age
Senior

Donor Health
Clinically diagnosed with degenerative Osteoarthritis. The leukocyte population exhibits a low-grade systemic inflammatory profile, specifically showing alterations in monocyte-derived macrophage polarization related to cartilage metabolic turnover.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, standard high-viability formulation to preserve innate immune cell subsets and senescent cell markers.

Additional Donor Information
Each lot features a Leukopak from donors with radiographically confirmed OA. Profiles include joint involvement sites and pain severity, supporting research into the role of low-grade systemic inflammation in degenerative joint disease.

Clinical Profile
Affected joints, Kellgren-Lawrence radiographic grading, pain/functionality scores, and history of intra-articular injections or orthopedic interventions.

Additional Information

Medication History
Available upon request. Documentation of chronic NSAID use, analgesics, and history of intra-articular corticosteroid or hyaluronic acid injections.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Osteoarthritis Donor, Leukopak, Osteoarthritis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Osteoarthritis Donor (XS-0426-XU256). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.